Probleme bei der Darstellung von ARIVA.DE?

  • Laden unsere Charts bei Ihnen nicht?
  • Wird unser Forum bei Ihnen nicht korrekt dargestellt?

Sie nutzen einen Adblocker, der hierfür verantwortlich ist. Hierauf hat ARIVA.DE leider keinen Einfluss. Bitte heben Sie die Blockierung von ARIVA.DE in Ihrem Adblocker auf.

Probleme bei der Darstellung von ARIVA.DE?

AGILE NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm

Montag, 09.01.2017 21:20 von

PR Newswire

NEW YORK, Jan. 9, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Agile Therapeutics, Inc. ("Agile" or the "Company") (NASDAQ:AGRX).

Faruqi & Faruqi, LLP.

The investigation focuses on whether the Company and its executives violated federal securities laws.

Specifically, aftermarket hours on January 3, 2017, the Company released data from its Phase 3 SECURE study evaluating the Company's contraceptive patch, Twirla.  Among the results, the Company stated that 51.4% of subjects had withdrawn from the study and that 1.7% of test subjects suffered "serious adverse events."  On this news, Agile's share price significantly declined.

Request more information now by clicking here:  www.faruqilaw.com/AGRX. There is no cost or obligation to you.

Take Action

If you invested in Agile stock or options and would like to discuss your legal rights, visit www.faruqilaw.com/AGRX.  You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Agile's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/agile-notification-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-50000-investing-in-agile-therapeutics-inc-to-contact-the-firm-300388011.html

SOURCE Faruqi & Faruqi, LLP